CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing personalized immunotherapy for sepsis, a severe infection-related condition. It aims to create a theranostics platform that utilizes comprehensive biological data to tailor treatments for individual patients, potentially improving outcomes in sepsis care.
Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection, and is characterized by a high mortality of up to 30-40%.
Treatment of sepsis was revolutionized by two steps that significantly decreased mortality: antibiotics and the intensive care units.
It has been hoped that a third revolution, immunotherapy, would further improve outcome of sepsis, but this hope did not materialize.
This was due to the incompletely understood pathophysiology, and the heter…
STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
HELLENIC INSTITUTE FOR THE STUDY OF SEPSIS
Greece, ATHENS
Type: Research institute
Activity type: Research Organisations
SME: Yes
Switzerland, Lausanne
Type: Public body
Activity type: Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
SME: No
Germany, Jena
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Netherlands, Amsterdam
Type: Research institute
Activity type: Research Organisations
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
